Life Sciences Archives - Life Sciences Times

Philips to Invest Over $150 Million in U.S. Manufacturing and R&D Expansion

August 15, 2025

PureTech Launches Celea Therapeutics to Advance Treatment of Serious Respiratory Diseases

August 12, 2025

First Patient Dosed in Phase 3 Trial of Potential Dravet Syndrome Treatment

August 11, 2025

THIS WEEK'S STORIES

Nu-Tek BioSciences to Showcase Animal-Free Cell Culture and Fermentation Solutions at BPI East 2025

August 14, 2025

PureTech Launches Celea Therapeutics to Advance Treatment of Serious Respiratory Diseases

August 12, 2025

Merck’s KEYTRUDA-Padcev Combo Improves Survival for Cisplatin-Ineligible Muscle-Invasive Bladder Cancer Patients in Phase 3 Trial

August 12, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Tag: Life Sciences

Most Read

Tishman Speyer Provides $25.2 Million Mezzanine Financing for Life Sciences Lab Building

Bayer Brings Popular Mexican Pain Reliever Aspirina to U.S. Market

Philips to Invest Over $150 Million in U.S. Manufacturing and R&D Expansion

Vyome Marks Nasdaq Debut as ‘HIND’ on Indian Independence Day

EDITOR PICKS

Philips to Invest Over $150 Million in U.S. Manufacturing and R&D Expansion

PureTech Launches Celea Therapeutics to Advance Treatment of Serious Respiratory Diseases

First Patient Dosed in Phase 3 Trial of Potential Dravet Syndrome Treatment

THIS WEEK'S STORIES

Nu-Tek BioSciences to Showcase Animal-Free Cell Culture and Fermentation Solutions at BPI East 2025

PureTech Launches Celea Therapeutics to Advance Treatment of Serious Respiratory Diseases

Merck’s KEYTRUDA-Padcev Combo Improves Survival for Cisplatin-Ineligible Muscle-Invasive Bladder Cancer Patients in Phase 3 Trial

POPULAR CATEGORY

ABOUT US

FOLLOW US